{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,3]],"date-time":"2024-11-03T04:03:06Z","timestamp":1730606586201,"version":"3.28.0"},"reference-count":15,"publisher":"Japanese Society of Internal Medicine","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2024,11,1]]},"DOI":"10.2169\/internalmedicine.3384-23","type":"journal-article","created":{"date-parts":[[2024,3,3]],"date-time":"2024-03-03T22:17:53Z","timestamp":1709504273000},"page":"2987-2990","source":"Crossref","is-referenced-by-count":0,"title":["Successful Immunosuppressive Therapy for Interstitial Lung Disease Associated with Sj\u00f6gren's Syndrome with Double-positive Anti-SS-A and Anti-centromere Antibodies"],"prefix":"10.2169","volume":"63","author":[{"given":"Koji","family":"Suzuki","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Akiyama","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Kondo","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuntaro","family":"Saito","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironari","family":"Hanaoka","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Shiboski CH, Shiboski SC, Seror R, et al.; the International Sj\u00f6gren's Syndrome Criteria Working Group. 2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sj\u00f6gren's syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol 69: 35-45, 2017.","DOI":"10.1002\/art.39859"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Yoshimi R, Ueda A, Ozato K, Ishigatsubo Y. Clinical and pathological roles of Ro\/SSA autoantibody system. Clin Dev Immunol 2012: 606195, 2012.","DOI":"10.1155\/2012\/606195"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Tsukamoto M, Suzuki K, Takeuchi T. Clinical and immunological features of anti-centromere antibody-positive primary Sj\u00f6gren's syndrome. Rheumatol Ther 5: 499-505, 2018.","DOI":"10.1007\/s40744-018-0126-2"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Suzuki Y, Fujii H, Nomura H, et al. Impact of double positive for anti-centromere and anti-SS-a\/Ro antibodies on clinicopathological characteristics of primary Sj\u00f6gren's syndrome: a retrospective cohort study. Mod Rheumatol 28: 872-878, 2018.","DOI":"10.1080\/14397595.2017.1418164"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Gupta S, Ferrada MA, Hasni SA. Pulmonary manifestations of primary Sj\u00f6gren's syndrome: underlying immunological mechanisms, clinical presentation, and management. Front Immunol 10: 1327, 2019.","DOI":"10.3389\/fimmu.2019.01327"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Zhao R, Wang Y, Zhou W, et al. Associated factors with interstitial lung disease and health-related quality of life in Chinese patients with primary Sj\u00f6gren's syndrome. Clin Rheumatol 39: 483-489, 2020.","DOI":"10.1007\/s10067-019-04753-5"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Vacchi C, Sebastiani M, Cassone G, et al. Therapeutic options for the treatment of interstitial lung disease related to connective tissue diseases. A narrative review. J Clin Med 9: 407, 2020.","DOI":"10.3390\/jcm9020407"},{"key":"8","unstructured":"8. Ministry of Education, Culture, Sports, Science and Technology. Report book on the survey of physical fitness and athletic ability. [cited 2023 Nov 16]. Available from: https:\/\/www.mext.go.jp\/sports\/content\/20221011-spt_kensport01-000025410_6.pdf."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Seror R, Ravaud P, Bowman SJ, et al.; the EULAR Sj\u00f6gren's Task Force. EULAR Sj\u00f6gren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sj\u00f6gren's syndrome. Ann Rheum Dis 69: 1103-1109, 2010.","DOI":"10.1136\/ard.2009.110619"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Roca F, Dominique S, Schmidt J, Smail A, Duhaut P, L\u00e9vesque H, et al. Interstitial lung disease in primary Sj\u00f6gren's syndrome. Autoimmun Rev 16: 48-54, 2017.","DOI":"10.1016\/j.autrev.2016.09.017"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Zhang T, Yuan F, Xu L, Sun W, Liu L, Xue J. Characteristics of patients with primary Sj\u00f6gren's syndrome associated interstitial lung disease and relevant features of disease progression. Clin Rheumatol 39: 1561-1568, 2020.","DOI":"10.1007\/s10067-019-04906-6"},{"key":"12","unstructured":"12. Ramos-Casals M, Brito-Zer\u00f3n P, Bombardieri S, et al.; the EULAR-Sj\u00f6gren Syndrome Task Force Group. EULAR recommendations for the management of Sj\u00f6gren's syndrome with topical and systemic therapies. Ann Rheum Dis 79: 3-18, 2020."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. American Thoracic Society, European Respiratory Society. American Thoracic Society\/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 165: 277-304, 2002.","DOI":"10.1164\/ajrccm.165.2.ats01"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Park IN, Jegal Y, Kim DS, et al. Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia. Eur Respir J 33: 68-76, 2009.","DOI":"10.1183\/09031936.00158507"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Leslie KO. Historical perspective: a pathologic approach to the classification of idiopathic interstitial pneumonias. Chest 128: 513S-519S, 2005.","DOI":"10.1378\/chest.128.5_suppl_1.513S"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/21\/63_3384-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T03:31:59Z","timestamp":1730518319000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/21\/63_3384-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,1]]},"references-count":15,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.3384-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"type":"print","value":"0918-2918"},{"type":"electronic","value":"1349-7235"}],"subject":[],"published":{"date-parts":[[2024,11,1]]},"article-number":"3384-23"}}